PHASE-2B, DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE ACTIVITY AND SAFETY OF INEBILIZUMAB IN ANTI-NMDA RECEPTOR ENCEPHALITIS AND ASSESS MARKERS OF DISEASE
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Amanda Piquet
Study ID
Protocol Number: 24-0268
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers